National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1295 out of 2,175

Result pages: prev   1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304   next


VAERS ID: 1265026 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-24
Onset:2021-03-29
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9470 / 1 LA / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER UNK / UNK - / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Angiogram, Blood pressure systolic, Cardiac tamponade, Cardiogenic shock, Coronary artery stenosis, Ejection fraction, International normalised ratio, Mitral valve incompetence, Multiple organ dysfunction syndrome, Pericardial haemorrhage, Pulmonary arterial pressure increased, Vasoplegia syndrome, Ventricular hypokinesia
SMQs:, Cardiac failure (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Pulmonary hypertension (narrow), Cardiomyopathy (broad), Other ischaemic heart disease (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: BISOCE; EUPANTOL; LERCAN
Current Illness: Ischaemic heart disease
Preexisting Conditions: Medical History/Concurrent Conditions: Acute coronary syndrome (requiring the placement of active stents); Arterial hypertension; Artificial cardiac pacemaker user; Atrial fibrillation; Atrioventricular block complete (with permanent cardiac pacemaker); Chronic unstable angina; Dialysis (3 times a week); Dyslipidemia; End stage renal disease (ESRD); Hypothyroidism; Ketosis-prone diabetes mellitus; Stent insertion NOS (circumflex artery,common trunk and proximal left anterior descending artery)
Allergies:
Diagnostic Lab Data: Test Date: 20210329; Test Name: coronary angiography; Result Unstructured Data: Test Result:reveals a very tight intrastent stenosi; Comments: very tight intrastent stenosis of the common trunk and the right coronary artery; Test Date: 20210329; Test Name: systolic pulmonary artery pressure; Result Unstructured Data: Test Result:45 mmHg; Test Date: 20210329; Test Name: Left ventricular ejection fraction; Result Unstructured Data: Test Result:35-40 %; Comments: apical hypokinesia, restrictive grade 2 mitral insufficiency; Test Date: 20210329; Test Name: INR; Result Unstructured Data: Test Result:2.75
CDC Split Type: FRPFIZER INC2021447074

Write-up: apical hypokinesia; grade 2 mitral insufficiency; PAPS (systolic pulmonary artery pressure) at 45mmHg; very tight intrastent stenosis of the common trunk and the right coronary artery; Multiple organ failure; mixed shock (cardiogenic and vasoplegic); mixed shock (cardiogenic and vasoplegic); Haemopericardium; Tamponade cardiac; This is a spontaneous report from a contactable physician downloaded from a regulatory authority- WEB FR-AFSSAPS-AM20210929, Safety Report Unique Identifier FR-AFSSAPS-2021037085, received from the regulatory authority. An 82-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in the left deltoid on 24Mar2021 (Lot Number: ER9470) as single dose for covid-19 vaccination; warfarin sodium (COUMADINE), oral from an unspecified date to 29Mar2021, at 2 mg, daily for atrial fibrillation; acetylsalicylate lysine (KARDEGIC), oral from 2020 to 29Mar2021, at 75 mg, daily for anti atherothrombosis prevention; and ticagrelor (BRILIQUE), oral from 2020 to 29Mar2021, at 90 mg, daily for anti atherothrombosis prevention. Medical history included heavy cardiovascular history: ischemic heart disease since 2018 and ongoing, acute coronary syndrome from 2020 requiring the placement of active stents (circumflex artery, common trunk and proximal left anterior descending artery), atrioventricular block complete with permanent cardiac pacemaker, chronic unstable angina from 2017. This patient also has atrial fibrillation, Ketosis-prone diabetes mellitus, arterial hypertension, dyslipidemia, hypothyroidism from 2018, end-stage renal disease (ESRD) on dialysis 3 times a week. Concomitant medications included bisoprolol fumarate (BISOCE); pantoprazole sodium sesquihydrate (EUPANTOL); and lercanidipine hydrochloride (LERCAN). The patient experienced haemopericardium and tamponade cardiac; both on 29Mar2021, fatal events. On 24Mar2021, patient was vaccinated by COMIRNATY. On 29Mar2021, significant chest pain, motivating his hospitalization. LVEF (Left ventricular ejection fraction) at 35-40%, apical hypokinesia, restrictive grade 2 mitral insufficiency, PAPS (systolic pulmonary artery pressure) at 45mmHg. The coronary angiography reveals a very tight intrastent stenosis of the common trunk and the right coronary artery. Surgical management for triple coronary artery bypass grafting. INR = 2.75. Prior antagonization with PPSB (Prothrombin-Proconvertin-Stuart factor B), vitamin K, red blood cells. Post-surgical complication by a compressive hemopericardium associated with hemodynamic degradation. Multiple organ failure table. Resumption in the operating room in emergency but state of mixed shock (cardiogenic and vasoplegic) requiring the administration of a high dose of catecholamines. Despite intensive resuscitation, the condition did not improve and patient died on 01Apr2021. It was not reported if an autopsy was performed. The action taken in response to the events for warfarin sodium, acetylsalicylate lysine, and for ticagrelor was reported as permanently withdrawn on 29Mar2021. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Hemopericardium; tamponade cardiac; stenosis of the common trunk and the right coronary artery; PAPS (systolic pulmonary artery pressure) at 45mmHg; grade 2 mitral insufficiency; apical hypokinesia; mixed shock (cardiogenic and vasoplegic); mixed sho


VAERS ID: 1265029 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-05
Onset:2021-03-16
   Days after vaccination:39
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-02
   Days after onset: 17
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Living in nursing home
Preexisting Conditions: Medical History/Concurrent Conditions: Arterial hypertension; Dementia; Meningioma surgery
Allergies:
Diagnostic Lab Data: Test Date: 20210316; Test Name: Covid-19 PCR test; Test Result: Positive
CDC Split Type: FRPFIZER INC2021447014

Write-up: Vaccination failure/Patient PCR + (positive) COVID on 16Mar2021, 39 days after the second dose; Patient PCR + (positive) COVID on 16Mar2021, 39 days after the second dose; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-BX20213213. An 84-year-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular, administered in left arm on 05Feb2021 (lot number: EJ6788) as single dose, and dose 1 intramuscular, administered in right arm on 16Jan2021 (lot number: EJ6795) as single dose for COVID-19 immunisation. Medical history included dementia, meningioma surgery, arterial hypertension; all from an unknown date and unknown if ongoing, and ongoing residing in nursing homes. The patient''s concomitant medications were not reported. The patient experienced vaccination failure/patient PCR + (positive) COVID on 16Mar2021, 39 days after the second dose. Lung deterioration 3 days later, implementation of comfort care in agreement with the family, death on 02Apr2021. No information on the variant. The patient underwent COVID-19 PCR test: positive on 16Mar2021. The patient died on 02Apr2021 due to COVID-19 infection. An autopsy was not performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Infection COVID


VAERS ID: 1265030 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-26
Onset:2021-02-27
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Decreased appetite, Pneumonia
SMQs:, Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 15 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cancer of lung (treatment in progress, if any, not specified); Non-insulin-dependent diabetes mellitus (treatment in progress, if any, not specified)
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021446917

Write-up: Lung infection; Decreased appetite; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-BX20213276 with safety report unique identifier FR-AFSSAPS-2021039850. A 71-year-old male patient received the second dose of BNT162B2 (COMIRNATY, lot number EP2166), intramuscularly administered in the left arm on 26Feb2021 at a single dose for covid-19 immunization. Medical history included non-insulin-dependent diabetes mellitus and, cancer of lung - "treatment in progress, if any, not specified". The patient has not had covid-19. The patient''s concomitant medications were not reported. The patient experienced decreased appetite on 27Feb2021 with outcome of not recovered. At 1 month of vaccination, on 26Mar2021, the patient had lung infection with aggravation and hospitalization for 15 days (from an unspecified date in 2021 to an unspecified date in 2021) - the outcome was fatal. It was also reported "death of the patient - cause unknown" (pending clarification). The patient died on an unspecified date in 2021. It was unknown if an autopsy was performed. The patient has not been tested for covid-19 since the vaccination. Imputation made without prejudice to the elements of investigations which could be carried out within the framework of legal or amicable compensation procedures.; Reported Cause(s) of Death: lung infection


VAERS ID: 1265031 (history)  
Form: Version 2.0  
Age: 93.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-14
Onset:2021-04-14
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2246 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Cardio-respiratory arrest, Haemoglobin, Heart rate, Oxygen saturation
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FUROSEMIDE; ALPRAZOLAM; TARDYFERON; HALOPERIDOL; THERALENE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arterial hypertension; Cognitive disorders (unlabeled cognitive disorders (shouting, slapping, insulting)); Iron deficiency anemia (hemoglobin at 8.4g / dL on 03Mar2021 and 7.3 g / dL on 12Feb2021 - N = 12-16 g / dL)
Allergies:
Diagnostic Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:6/3; Test Name: blood pressure; Result Unstructured Data: Test Result:115/60 mmHg; Comments: Post vaccination constants at 9:58 am; Test Name: blood pressure; Result Unstructured Data: Test Result:80/60 mmHg; Test Date: 20210212; Test Name: hemoglobin; Result Unstructured Data: Test Result:7.3 g/dl; Test Date: 20210303; Test Name: hemoglobin; Result Unstructured Data: Test Result:8.4 g/dl; Test Name: pulse; Result Unstructured Data: Test Result:76 bpm; Comments: Post vaccination constants at 9:58 am; Test Name: Oxygen saturation; Test Result: 95 %; Comments: Post vaccination constants at 9:58 am
CDC Split Type: FRPFIZER INC2021446992

Write-up: Cardio-respiratory arrest; This is a spontaneous report from a contactable healthcare professional downloaded from the regulatory authority-WEB, regulatory authority FR-AFSSAPS-CN20211258, Safety Report Unique Identifier FR-AFSSAPS-2021038541. A 93-year-old female patient received bnt162b2 (COMIRNATY), dose 1 intramuscular, administered in Arm Left on 14Mar2021 09:49 (Batch/Lot Number: EW2246) as single dose for covid-19 immunisation. Medical history included arterial hypertension, iron deficiency anemia (hemoglobin at 8.4g / dL on 03Mar2021 and 7.3 g / dL on 12Feb2021 - N = 12-16 g / dL) and unlabeled cognitive disorders (shouting, slapping, insulting). The patient has no history of COVID-19 and PCR test history. Concomitant medications included furosemide, alprazolam, ferrous sulfate (TARDYFERON), haloperidol and alimemazine tartrate (THERALENE). The patient experienced cardio-respiratory arrest on 14Apr2021. The patient was vaccinated at 9:49 AM in the presence of her daughter. Post vaccination constants at 9:58 am: BP 115/60 mmHg, Pulse 76 bpm and Sat O2 at 95%. She then stayed in bed to rest until the caregiver arrived for toilet assistance. Usual behavior at the start of treatment: the patient screams and slaps. During the nursing treatment at 10:45 AM, the patient became unwell including loss of consciousness, cyanosis and mottling, the caregiver put the patient back to bed and called the nurse (10:50 am). The vaccination team intervened immediately and carried out cardio-pulmonary resuscitation: O2 15l.mn in a high concentration mask, BP 6/3, impregnable pulse and saturation, raised legs, no trace on the ECG. After a few minutes, BP at 80/60 mmHg dextro 1.28 with injection of 2 pens of adrenaline 300 in s / c. Put patch for shock to the defibrillator; shock was not advised by the PLC; new injection of 0.3mg of adrenaline. Upon arrival of firefighters, cardiac massage and BAVU performed. On SMUR (The Mobile Emergency and Resuscitation Service) arrival, cardiopulmonary resuscitation, IV line installation, and administration of adrenaline done; ineffective resuscitation noted, reaction stop and O2 installation at 15l.mn while waiting for the family. In total, there was a cardiopulmonary arrest on the day of the vaccination, resulting in the death of the patient. The patient died around 13:05. It was unknown if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Cardio-respiratory arrest


VAERS ID: 1265032 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-02
Onset:2021-03-30
   Days after vaccination:56
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19 pneumonia, Cardiac failure, SARS-CoV-2 test, Vaccination failure
SMQs:, Cardiac failure (narrow), Lack of efficacy/effect (narrow), Cardiomyopathy (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-04
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; COPD; Deep vein thrombosis; Dependence on ventilator (Dependence on non-invasive nocturnal ventilation); Diabetes; Hypertensive heart disease; Ischaemic heart disease; Peripheral arteritis
Allergies:
Diagnostic Lab Data: Test Date: 20210331; Test Name: nasopharyngeal PCR screening of SARS CoV2; Test Result: Positive ; Comments: 20l / 501Y.V1
CDC Split Type: FRPFIZER INC2021446970

Write-up: myocardial suffering/cardiac decompensation; Vaccination failure/ bronchopneumonia/ PCR which was carried out on 31Mar2021 with a positive result; COVID-19 confirmed by positive COVID-19 test/ bronchopneumonia; This is a spontaneous report received from a contactable pharmacist downloaded from the regulatory authority-WEB. The regulatory authority report number is FR-AFSSAPS-DJ20210848, Safety report unique identifier FR-AFSSAPS-2021035663. A 92-year-old male patient received BNT162B2 (COMIRNATY), first dose intramuscular on 12Jan2021 as a single dose, then second dose intramuscular on 02Feb2021 as a single dose for COVID-19 vaccination. Medical history included AFib/ complete arrhythmia by atrial fibrillation, Hypertensive heart disease, Peripheral arteritis/arteritis of the lower limbs, COPD (chronic obstructive pulmonary disease), Diabetes, Deep vein thrombosis, Ischaemic heart diseasea and Dependence on ventilator/ Dependence on non-invasive nocturnal ventilation. The patient is residing in a residential establishment for dependent elderly people. The patient presented the first symptoms of bronchopneumonia on 30Mar2021. The attending physician examined him on 30Mar2021 and recommended a PCR which was carried out on 31Mar2021 with a positive result at the end of the day. The patient was asthenic, dyspneic and fluctuating oxygen-dependent. The patient has COVID-19 confirmed by positive COVID-19 test. He was transferred to a hospital but died on 04Apr2021 in a context of myocardial suffering linked to the COVID infection which led to cardiac decompensation. His condition deteriorated despite treatment with oxygen therapy at 3L/min, amoxicillin, clavulanic acid (AUGMENTIN) and prednisone (CORTANCY) at 40 mg/day and aerosols. The receipt of the nasopharyngeal PCR screening of SARS CoV2: English variant 20l / 501Y.V1 on 31Mar2021. In total: vaccine failure with COVID infection. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Vaccination failure/ bronchopneumonia/ PCR which was carried out on 31Mar2021 with a positive result; COVID-19 confirmed by positive COVID-19 test/ bronchopneumonia; myocardial suffering/cardiac decompensation


VAERS ID: 1265033 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-23
Onset:2021-02-28
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6789 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-28
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021453387

Write-up: cardiac arrest; This is a spontaneous report from a contactable consumer (patient''s daughter) from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-DJ20210927. An 80 years old female patient received the second dose of (COMIRNATY, Lot/batch no. EJ6789) intramuscularly at single dose for COVID-19 immunisation on 23Feb2021. Relevant history and concomitant drug was unknown. COVID-19 disease history: NO. Relevant history and concomitant drugs were unknown. The patient''s daughter reported the occurrence of her mother''s death on 28Feb2021. She explained, "This is not really a side effect but rather a fact. Mom died 5 days after the second dose of the vaccine. Apparently the cause of death is cardiac arrest." No autopsy was performed. The death certificate mentioned a death at home. Comments: In total, death of a patient at D + 5 of the injection of a second dose of the COMIRNATY vaccine. No other additional information in the declaration (history, tolerance of the vaccine, context of death). request for additional information made to the reporter but no response to date. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: cardiac arrest


VAERS ID: 1265034 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-29
Onset:2021-04-06
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2166 / 2 - / OT
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER UNKNOWN / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral haematoma, Coma scale abnormal, Disturbance in attention, Hemiplegia, International normalised ratio, Magnetic resonance imaging head, Mydriasis
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Depression (excl suicide and self injury) (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-09
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: DIGOXIN; BISOPROLOL; ATORVASTATIN; ESOMEPRAZOLE; DITROPAN; DICETEL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Appendectomy; Atrial fibrillation; Bowel obstruction; Cataract; Gastroesophageal reflux disease; Hysterectomy; Lumbar pain (Narrow lumbar canal operated in 2015 with chronic pain); Ovariectomy; Rectal prolapse; Surgery (Narrow lumbar canal operated in 2015); Transient ischemic attack
Allergies:
Diagnostic Lab Data: Test Name: INR; Result Unstructured Data: Test Result:3.77; Test Name: INR; Result Unstructured Data: Test Result:1.48; Test Name: Brain MRI; Result Unstructured Data: Test Result:large right hemispherical intraparenchymal hemato; Comments: large right hemispherical intraparenchymal hematoma with ventricular flooding
CDC Split Type: FRPFIZER INC2021446963

Write-up: glasgow 4 coma; onset of sudden left hemiplegia; disturbances in vigilance; areactive right mydriasis; Haematoma cerebral; This is a spontaneous report from a contactable pharmacist downloaded from the regulatory authority-WEB FR-AFSSAPS-GR20211253, Safety Report Unique Identifier FR-AFSSAPS-2021039228. An 80-year-old female patient received the second dose of bnt162b2 (COMIRNATY; Lot Number: EP2166), intramuscular on 29Mar2021 at 30 ug, single for covid-19 immunization and fluindione (PREVISCAN [FLUINDIONE]), oral from an unspecified date (Batch/Lot Number: Unknown) to an unspecified date, at 20 mg: alternating 1/4 tablet and 1/2 tablet every other day for atrial fibrillation. Medical history included complete arrhythmia due to atrial fibrillation; concept of stroke /transient ischemic attack without further precision, gastroesophageal reflux disease, narrow lumbar canal operated in 2015 with chronic pain, bowel obstruction, appendectomy, hysterectomy, ovariectomy, rectal prolapse and cataract. Concomitant medications included digoxin (DIGOXIN); bisoprolol (BISOPROLOL); atorvastatin (ATORVASTATIN); esomeprazole (ESOMEPRAZOLE); oxybutynin hydrochloride (DITROPAN) and pinaverium bromide (DICETEL); all taken for an unspecified indication, start and stop date were not reported. The patient received first dose of COVID vaccine Comirnaty (lot number: UNKNOWN) on 03Mar2021 at single dose for COVID-19 immunization. On 06Apr2021, onset of sudden left hemiplegia with deviation to the right of the head and eyes and disturbances in vigilance; HT surge with PAS$g 200 mmHg casued hospitalization. Unfavorable neurological evolution with persistence of vigilance disorder, glasgow 4 coma then areactive right mydriasis. Overall, the patient presented with an intracerebral hematoma on 06Apr2021. The patient underwent lab tests and procedures which included international normalised ratio: 3.77 on an unspecified date, international normalised ratio: 1.48 on an unspecified date and magnetic resonance imaging brain: large right hemispherical intraparenchymal hematoma with ventricular flooding. The patient died on 09Apr2021. An autopsy was not performed. No follow-up attempts are possible. Information about lot/batch number of 1st dose cannot be obtained.; Reported Cause(s) of Death: neurological sequelae following an intracerebral hematoma


VAERS ID: 1265035 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-09
Onset:2021-04-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2239 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Death
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Coronary stent user; Ischaemic heart disease
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021453650

Write-up: Death NOS; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB FR-AFSSAPS-MA20211367 Sender''s (Case) Safety Report Unique Identifier FR-AFSSAPS-2021040308. A 64-years-old male patient received the first dose of bnt162b2 (COMIRNATY), intramuscular in the left arm on 09Apr2021 (Batch/Lot Number: EW2239) as single dose for covid-19 immunisation. Medical history included Cardiovascular (IAS), stented ischemic heart disease, patient at risk of developing severe form of COVID disease, no history of COVID disease. The patient''s concomitant medications were not reported. The patient died on 10Apr2021. An autopsy was not performed. No follow-up attempts are possible.; Reported Cause(s) of Death: Death NOS


VAERS ID: 1265037 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-16
Onset:2021-03-15
   Days after vaccination:27
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood creatinine, Blood osmolarity, Blood pressure measurement, Blood sodium, Blood sodium increased, Blood urea, Body temperature, Brain natriuretic peptide, C-reactive protein, COVID-19, COVID-19 pneumonia, Dehydration, Disorientation, Fibrin D dimer, Heart rate, Imaging procedure, Investigation, Neutrophil count, Oxygen saturation, Platelet count, Renal function test, SARS-CoV-2 test, Superinfection, Troponin, Vaccination failure, White blood cell count
SMQs:, Lack of efficacy/effect (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Dehydration (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-04
   Days after onset: 20
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Bronchopulmonary disease; Calculus biliary; Follicular B-cell non-Hodgkin''s lymphoma; Macular degeneration; Prostate adenoma; Renal failure
Allergies:
Diagnostic Lab Data: Test Date: 20210329; Test Name: serum creatinine; Result Unstructured Data: Test Result:137 umol/l; Test Date: 20210329; Test Name: osmolarity; Result Unstructured Data: Test Result:338 mosm/L; Test Date: 20210329; Test Name: blood pressure; Result Unstructured Data: Test Result:152/75 mmHg; Test Date: 20210329; Test Name: Na; Result Unstructured Data: Test Result:153 mmol/L; Test Date: 20210329; Test Name: urea; Result Unstructured Data: Test Result:14.7 mmol/L; Test Date: 20210329; Test Name: body temperature; Result Unstructured Data: Test Result:36.2 Centigrade; Test Date: 20210329; Test Name: Brain natriuretic peptide; Result Unstructured Data: Test Result:34 pg/mL; Test Date: 20210329; Test Name: crp; Result Unstructured Data: Test Result:237 mg/l; Test Date: 20210329; Test Name: ddimer; Result Unstructured Data: Test Result:1300; Test Date: 20210329; Test Name: heart rate; Result Unstructured Data: Test Result:65; Comments: FC: 65 bpm; Test Date: 20210329; Test Name: Imaging; Result Unstructured Data: Test Result:Covid19; Comments: Covid19 type pneumonia with severe involvement (50/70%); Test Date: 20210329; Test Name: BU: Leuco / Nitrites / Blood; Result Unstructured Data: Test Result:- / - / traces; Comments: details: pro +; Test Date: 20210329; Test Name: gb; Result Unstructured Data: Test Result:15000; Comments: without lymphopenia; Test Date: 20210329; Test Name: GC; Result Unstructured Data: Test Result:1.06 g/l; Test Date: 20210329; Test Name: ScGw; Result Unstructured Data: Test Result:15 = Y4 / V5 / M6; Test Date: 20210329; Test Name: PNN; Result Unstructured Data: Test Result:83.7 g/l; Test Date: 20210329; Test Name: O2 saturation; Result Unstructured Data: Test Result:92%; Test Date: 20210329; Test Name: platelet; Result Unstructured Data: Test Result:191 x10 9/l; Test Date: 20210329; Test Name: ckd; Test Result: 40 mL; Test Date: 20210315; Test Name: PCR COVID; Test Result: Positive ; Test Date: 20210329; Test Name: troponin; Result Unstructured Data: Test Result:73; Test Date: 20210329; Test Name: hyperleukocytosis; Result Unstructured Data: Test Result:15 g/l
CDC Split Type: FRPFIZER INC2021431434

Write-up: Vaccination failure/tested PCR + for SARSCov2/Covid-19 type pneumonia with severe involvement (50/70%); Vaccination failure/tested PCR + for SARSCov2/Covid-19 type pneumonia with severe involvement (50/70%); Vaccination failure/tested PCR + for SARSCov2/Covid-19 type pneumonia with severe involvement (50/70%); COVID-19 complicated by superinfection; severe dehydration; disoriented; Na: 153 mmol/l; This is a spontaneous report from a contactable healthcare professional downloaded from the regulatory authority-WEB, regulatory authority number FR-AFSSAPS-NC20211590. This healthcare professional reported similar events for two patients. This is the first of two reports. An 85-year-old male patient received bnt162b2 (COMIRNATY), dose 1 intramuscular on 28Jan2021 (Batch/Lot Number: EJ6788/EJ6788) as single dose; and dose 2 via an unspecified route of administration on 16Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included prostate adenoma, macular degeneration, renal failure, biliary lithiasis, follicular B lymphoma in remission and post-chemotherapy pulmonary disease from 2014. The patient''s concomitant medications were not reported. The GIR2 patient residing in nursing house was vaccinated with COMIRNATY carried out on 28Jan2021 (D1) and 16Feb2021 (D2). On 15Mar2021, the patient tested PCR + for SARSCov2; the patient also presented abnormal "facies". Stability at first then degradation with desaturation which motivated his hospitalization on 29Mar2021. On admission (29Mar2021), PAS/PAD: 152/75 mmHg, FC (heart rate): 65 bpm , SAT/O2: 92% /6 l/min, T: 36.2 degrees C, GC: 1.06 g/l, ScGw: 15 = Y4/V5/M6, BU: Leuco/Nitrites/Blood: -/-/traces, details: pro +. Clinically, patient was conscious but disoriented, under O2 mask 6 l/min, cough, crackling of the 2 fields, supple calves, no other sign of HF. Biology showed D dimer 1300, BNP 34 pg/ml, CKD 40ml, gb 15000 without lymphopenia, tropo 73, hyperleukocytosis at 15 G/l at PNN (83.7 G/l), platelet 191 G/l, CRP 237 mg/l, Na: 153 mmol/l, urea: 14.7 mmol/l, serum creatinine 137 umol/l and osmolality 338 mosm/l. Imaging showed Covid-19 type pneumonia with severe involvement (50/70%). Diagnosis of COVID-19 complicated by superinfection and context of severe dehydration. No variant analysis performed at the time of his hospitalization. However, for all positive patients who were tested for a variant, the variant was found. Patient was placed on corticosteroids, Lovenox and augmentin before hospitalization. Other treatments inlcuded tamsulosin and Seresta. Rapid deterioration in hospital with fatal outcome on 04Apr2021 in the evening. Conclusion: Vaccine ineffectiveness with fatal outcome. The outcome of the events was unknown. The patient died on 04Apr2021 due to vaccination failure, COVID-19 and COVID-19 pneumonia. It was unknown if an autopsy was performed. The pharmacovigilant notes: Accountability score (s) established without prejudice to the elements of investigation which could be carried out within the framework of legal or amicable compensation procedures " No follow-up attempts possible. No further information expected.; Sender''s Comments: Linked Report(s) : FR-PFIZER INC-2021431443 same reporter/drug, similar events, diferent patients; Reported Cause(s) of Death: Vaccination failure/tested PCR + for SARSCov2/Covid-19 type pneumonia with severe involvement (50/70%); Vaccination failure/tested PCR + for SARSCov2/Covid-19 type pneumonia with severe involvement (50/70%); Vaccination failure/tested PCR + for SARSC


VAERS ID: 1265038 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-16
Onset:2021-03-02
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6789 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19 pneumonia, Computerised tomogram, General physical health deterioration, Loss of consciousness, Malaise, SARS-CoV-2 test, Vaccination failure
SMQs:, Torsade de pointes/QT prolongation (broad), Lack of efficacy/effect (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-18
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Arterial hypertension; Atrial fibrillation; Chronic haemodialysis; Ischaemic heart disease; Type II diabetes mellitus
Preexisting Conditions: Medical History/Concurrent Conditions: B-cell lymphoma (large cell B lymphoma treated in 2006 in remission); Factor V Leiden carrier
Allergies:
Diagnostic Lab Data: Test Date: 20210303; Test Name: CT scan; Result Unstructured Data: Test Result:minimal to moderate impairment.; Test Date: 20210302; Test Name: PCR Covid; Test Result: Positive ; Test Date: 20210303; Test Name: PCR Covid; Test Result: Positive ; Comments: variant
CDC Split Type: FRPFIZER INC2021447087

Write-up: Vaccination failure; Positive COVID test/COVID-19 pneumonia/COVID pneumonitis (variant); general condition deteriorated with malaise; general condition deteriorated with malaise; loss of consciousness; This is a spontaneous report received from a contactable pharmacist downloaded from the Medicine Agency (MA) Database-WEB. Regulatory authority report number is FR-AFSSAPS-NY20210769. A 75-year-old male patient received BNT162B2 (COMIRNATY), first dose on 26Jan2021 (Lot Number: EJ6788, unknown expiration) and second dose on 16Feb2021 (Lot Number: EJ6789, unknown expiration), both via intramuscular as a single dose for COVID-19 immunisation. Medical history included ongoing Type II diabetes mellitus, ongoing ischaemic heart disease, chronic haemodialysis since 2012, Factor V Leiden carrier, large cell B lymphoma treated in 2006 in remission, ongoing atrial fibrillation, and ongoing arterial hypertension. The patient''s concomitant medications were not reported. On 02Mar2021, the patient''s general condition deteriorated with malaise and loss of consciousness. Positive COVID test. Possible intrafamilial contamination. The patient experienced vaccination failure. The patient was hospitalized. On 03Mar2021, after intra-familial probable contamination, he developed COVID-19 pneumonia/COVID pneumonitis (South African variant); confirmation of the positive COVID test, variant V2 (South African), and died a few days later. CT scan showed minimal to moderate impairment. Management with oxygen therapy and dexamethasone 6 mg/d, antibiotic therapy and continued anticoagulant treatment with COUMADINE. Due to hydrosodic overload, a regular decrease of his dry weight in dialysis was necessary. Unfavorable evolution with respiratory deterioration requiring a high concentration mask that the patient regularly removed. Refusal of care. Decision of comfort care. Outcome of general condition deteriorated with malaise and loss of consciousness were unknown. The patient died on 18Mar2021 due to vaccination failure and positive COVID test/COVID-19 pneumonia/COVID pneumonitis (South African variant). It was unknown if an autopsy was performed. Reporter''s comment: Deadline of 15 days after vaccination. No information on the exact date of onset of the deterioration in general condition. No follow-up attempts are possible; information about batch number was already obtained.; Reported Cause(s) of Death: Positive COVID test/COVID-19 pneumonia/COVID pneumonitis (South African variant); Vaccination failure


Result pages: prev   1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1295&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166